Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006095 · ClinicalTrials.gov registry record
Neuroimaging Correlates of Memory Decline Following Carotid Interventions
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 207
- Enrollment target
NCT02006095: Completed study, sponsored by Stanford University.
NCT02006095 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02006095 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
Study Summary
Carotid revascularization can significantly reduce the risk of stroke in patients with severe carotid stenosis; however, it has been associated with cognitive decline in 25% of the older adults who undergo the procedure. Characterizing risk factors for cognitive decline following carotid interventions and individualizing treatment strategy based on those risks can minimize procedure-associated cognitive dysfunction. Neuroimaging techniques that characterize white matter integrity and regional hypoperfusion have the potential to provide sensitive brain structure indicators that may be associated with memory decline following revascularization procedures. In this protocol, we hope to determine how cerebral blood flow and baseline white matter abnormality in the vulnerable region modify the frequency and cognitive effect of microembolization following carotid revascularization procedures.
Primary Outcome
White matter abnormality and perfusion in correlation with microembolization and cognitive change
Interventions
- BEHAVIORAL Neuropsychological testing
- OTHER Magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2012-11 |
| Est. Completion | 2018-04 |
What the finished NCT02006095 record still lists
NCT02006095 is an observational study that tracks outcomes without assigning an intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Neuropsychological testing is the first listed.
NCT02006095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02006095 about?
NCT02006095 is a clinical study titled "Neuroimaging Correlates of Memory Decline Following Carotid Interventions". Carotid revascularization can significantly reduce the risk of stroke in patients with severe carotid stenosis; however, it has been associated with cognitive decline in 25% of the older adults who undergo the procedure. Characterizing risk factors for cognitive decline following carotid interventio...
What is the current status of trial NCT02006095?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2012-11. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02006095?
The interventions under investigation include: Neuropsychological testing (BEHAVIORAL), Magnetic resonance imaging (OTHER).
Who is sponsoring clinical trial NCT02006095?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia